France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

We think Avery Dennison benefits from durable competitive advantages that should support economic profits for at least the next 10 years. We assign the company a narrow moat rating based on its cost ...

General Dynamics reported a 27% rise in first-quarter profit on Wednesday, driven by strength in its defense units owing to ...

East Hartford jet-engine maker Pratt & Whitney reported a 41% increase in operating profits during the first quarter of 2025, but its parent company warned of a significant potential impact from the ...